Main menu

Resolving vector insertion sites and cell line characterization with long-read sequencing: insights from PRINT

  • Published on:

In this on-demand webinar, hear Kyle Burbach (Addition Therapeutics) present data from platform development and pre-clinical work using PRINT, a site-specific transgene integration platform. The talk highlights the use of Oxford Nanopore long-read sequencing to investigate insertion specificity in primary human hepatocytes, characterize rDNA methylation, assess transgene integrity, and apply sensitive alignment strategies for accurate detection of integration events.

You'll also get an overview of nanopore sequencing, and see how Oxford Nanopore platforms can support vector insertion site analysis using approaches such as whole-genome sequencing and adaptive sampling.

Authors: Kyle Burbach, Addition Therapeutics; Mia Rapoza Peterson, Oxford Nanopore Technologies

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Modern slavery policy Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag